Bacillimidazoles A−F, Imidazolium-Containing Compounds Isolated from a Marine <i>Bacillus</i>

Chemical investigations of a marine sponge-associated <i>Bacillus</i> revealed six new imidazolium-containing compounds, bacillimidazoles A–F (<b>1</b>–<b>6</b>). Previous reports of related imidazolium-containing natural products are rare. Initially unveiled by t...

Full description

Bibliographic Details
Main Authors: Jia-Xuan Yan, Qihao Wu, Eric J. N. Helfrich, Marc G. Chevrette, Doug R. Braun, Heino Heyman, Gene E. Ananiev, Scott R. Rajski, Cameron R. Currie, Jon Clardy, Tim S. Bugni
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/20/1/43
Description
Summary:Chemical investigations of a marine sponge-associated <i>Bacillus</i> revealed six new imidazolium-containing compounds, bacillimidazoles A–F (<b>1</b>–<b>6</b>). Previous reports of related imidazolium-containing natural products are rare. Initially unveiled by timsTOF (trapped ion mobility spectrometry) MS data, extensive HRMS and 1D and 2D NMR analyses enabled the structural elucidation of <b>1</b>–<b>6</b>. In addition, a plausible biosynthetic pathway to bacillimidazoles is proposed based on isotopic labeling experiments and invokes the highly reactive glycolytic adduct 2,3-butanedione. Combined, the results of structure elucidation efforts, isotopic labeling studies and bioinformatics suggest that <b>1</b>–<b>6</b> result from a fascinating intersection of primary and secondary metabolic pathways in <i>Bacillus</i> sp. WMMC1349. Antimicrobial assays revealed that, of <b>1</b>–<b>6</b>, only compound <b>six</b> displayed discernible antibacterial activity, despite the close structural similarities shared by all six natural products.
ISSN:1660-3397